Liquid Biopsy for Brain Tumors is advancing rapidly. Many opportunities to combine approaches to optimize diagnostics and therapeutic monitoring.

Congratulations to Dan Cahill, MD PhD, Vice Chair of Research MGH Neurosurgery for his promotion to @HarvardMed Professor of Neurosurgery! Dr. Cahill is an internationally recognized expert in neurosurgical oncology, with a special focus on IDH mutant glioma and research mentorship.

May is Brain Tumor Awareness Month. Please considering joining Row Republic and the Tagliente family in raising awareness to benefit neuro-oncologic research MGH Neurosurgery. Read more about their brain tumor journey here. because.massgeneral.org/rowrepublic

Brain Tumor Research: Did you know #craniopharyngiomas have a low mutation rate compared to other tumors? This lack of genetic complexity makes them susceptible to targeted therapies. More to follow on this in future posts.

Strong work in NEJM by Dr. Brastianos and my colleagues at MGH Neurosurgery and Brain Tumor News! Lot's of promise for targeted therapy for papillary #craniopharyngioma patients using BRAF-MEK inhibition. USC Brain Tumor Center (uscbtc) #braintumor #neurosurgery #NeuroTwitter #oncology

We are pleased to announce the 4th Annual Update in Neuro-Oncology HMS CME course in live and virtual format. Please join us for a high impact three day overview of the latest in neuro-oncology! Please share the following link and information with students, trainees, and staff

For neurosurgeons, MGB Neurosurgery MGH Neurosurgery Brigham and Women's Neurosurgery make note of the Master Class led by Brian Nahed MD MSC FCNS FAANS FACS on intraoperative ultrasound. Register here web.cvent.com/event/ef4913e1…

Join us!

For patients: I have a headache...do I need an MRI? Headaches are common, but rarely signal a brain tumor. However, for those with tumors, headaches often accompany other neurological symptoms. Assess for red flags and consider neuroimaging. #BrainTumor #Headache #Neuroscience

.Leonora Balaj Bob Carter MD PhD @SmaheenBatool1 develop an RNA-based Droplet Digital PCR assay to detect key #IDH1 mutation in plasma biopsies from #glioma patients with high sensitivity #CancerResearch Cancer at Nature Portfolio nature.com/articles/s4146…

In a new Nature Communications publication, researchers from MGH Neurosurgery and colleagues created a blood-based assay for the detection of IDH1.R132H-mutant #gliomas. Read more: massgeneral.org/news/research-… Leonora Balaj Bob Carter MD PhD

Study on skull base meningiomas treated with stereotactic radiotherapy (SRT): 52.9% showed symptom improvement. Key predictors: younger age (optic neuropathy), shorter symptom duration (extraocular), & lower radiation dose (trigeminal). [DOI: 10.1080/02688697.2024.2427720]

Speaker Spotlight! Dr. Michael Lim, Professor and Chair of the Department of #Neurosurgery at Stanford Neurology & Neurological Sciences, will present "Immune Cell Exhaustion in GBM." To learn more about our annual meeting and register, please visit: sfneurological.member365.com/public/event/d… #NeuroTwitter #Neurology #Neuro

When Karolina Atsalis was diagnosed with a brain tumor in 2021, her friends rallied around her, establishing the Smiley Fund and raising funds for the Mass General Cancer Center, where Karolina received lifesaving care. spklr.io/6013LOYf

Nice review by Bryan D. Choi MD PhD and team MassGeneral News nature.com/articles/s4169…

Blockbuster relative citation ratio on IDH mutant tumors. pubmed.ncbi.nlm.nih.gov/37272516/

x.com/EditorNeuro/st…

x.com/JNeurooncol/st…

New Clinical Trial for Glioblastoma Patients! 🚨  We're excited to announce that Dr. Peruzzi has been approved to begin a Phase 1 trial for a new treatment targeting recurrent Glioblastoma. This trial is for patients who have tried at least one previous treatment and are eligible